focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksProteome Share News (PRM)

Share Price Information for Proteome (PRM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.50
Bid: 3.00
Ask: 4.00
Change: -0.40 (-10.26%)
Spread: 1.00 (33.333%)
Open: 3.90
High: 0.00
Low: 0.00
Prev. Close: 3.90
PRM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK WINNERS & LOSERS: 5G Deal Boosts Vodafone Shares

Thu, 25th Sep 2014 11:43

LONDON (Alliance News) - The following stocks are among the biggest risers and fallers within the main London indices midday Thursday.
-------
FTSE 100 WINNERS
-------
Vodafone Group, up 1.9%. Vodafone said it has sealed a partnership with Dresden University of Technology under which the pair will research and develop 5G technology. The company said the partnership is part of its programme to partner with universities, technology companies and industry groups on developing the next generation of wireless technology. Dresden University has recently opened a 5G lab, which will offer specific facilities for researchers to test and evaluated a wide range of 5G technologies, Vodafone said.

Shire, up 1%. The stock is up after the Irish drug company said it will pay USD56.5 million to settle a probe into its US sales and marketing practices for Adderall XR, Vyvanse Daytrana, Lialda and Pentasa for a period up to 2010. Its also paying USD2.9 million to resolve a similar complaint in Louisiana.
-------
FTSE 100 LOSERS
-------
Royal Mail, down 3.5%. The stock has fallen for a second day. On Wednesday, it was hurt by a profit warning from Dutch rival TNT, while on Thursday smaller UK rival UK Mail Group warned that parcel volumes had been lower than expected in recent weeks, prompting Investec to say the UK parcels sector has been going through a more challenging period that previously expected. On the plus side, UK politicians have launched an inquiry into Royal Mail's claims that it will struggle to fulfil its obligation to deliver to every address in the country six days a week for the same price due to intense competition in profitable areas, The Guardian reported. The paper said the business select committee launched an investigation on Wednesday following pressure from Royal Mail executives who complain that rival operator TNT is able to cherry-pick profitable delivery routes in big cities while Royal Mail must provide the same service to all 29 million addresses in the country as part of its legally binding universal service obligation.

Fresnillo, down 3.6%, Randgold Resources, down 2.7%, and Antofagasta, down 1.2%. The companies are down after gold hit its lowest price since early January.

Hammerson, down 2.7%. The retail-focused real estate investment trust said it will conduct a share placing to raise about GBP400 million to help fund the GBP180 million acquisition of the rest of the Highcross shopping centre in Leicester that it doesn't already own, a GBP100 million investment in a new outlet shopping centre venture, and GBP120 million to fund existing developments. The company will place 71.3 million new shares, which is 9.99% of its existing issued share capital.

J Sainsbury, down 1.1%. The supermarket chain is down after having its price target cut to 225 pence, from 280p, by JP Morgan and to 275p, from 330p, by Deutsche Bank. The company currently trades at 257.9p.

BHP Billiton, down 2.3%, Tullow Oil, down 1.4%, and BP, down 1.3%. The companies are down as Brent oil hits its lowest price since 2012 Wednesday.
-------
FTSE 250 WINNERS
-------
CSR, up 7.2%. The chip maker tops the mid-cap index after it said the Takeover Panel has granted an extension to the deadline for Microchip Technology Inc to make a bid for the company. CSR said the deadline for the US semiconductor maker to make a bid has been extended to October 15 in order to allow the two companies more time to conclude their discussions.

Amec, up 3.1%. UBS has upgraded the company's rating to Buy, from Neutral, with a price target increase to 1,215p, from 1,100p. The stock currently trades at 1,099p.

Cairn Energy, up 2%. The oil and gas explorer said it has signed a deal to farm-out a 10% interest in the Catcher oil field and adjacent acreage in the UK North Sea in return for Dyas UK Ltd funding exploration and development costs up to a cap of USD182 million, cutting its own development bill for the field by about USD380 million. In a statement, the company said Dyas will acquire a 10% stake in each of the P1430, P2040, P2070, P2077 and P2086 licences by funding the exploration and development work. That will leave Cairn with a 20% interest in the Catcher licence as a whole, but will reduce its capital expenditure in the area to the end of 2017 to USD200 million, down about USD380 million.
-------
FTSE 250 LOSERS
-------
Mitchells & Butlers, down 6.3%. The UK pubs and restaurant operator said total sales in the 51 weeks of its financial year grew by 3.8%, helped by better food and drink sales, but said that after strong demand in July following the World Cup, trading conditions in August slumped. In a pre-close trading update, the company said like-for-like sales in the 51 weeks to September 20 were up 0.6%, however it said growth in the nine weeks to September 20 was minimal, up only 0.1% as food sales grew by 0.1% and drink sales declined by 0.2%.

Enterprise Inns, down 2.7%. The weakening sector backdrop has been been unhelpful for the stock, said Shore Capital analyst Gerard Lane.

Vesuvius, down 1.8%. The company has been cut by Numis to Hold, from Add, with a target price of 515p. The stock currently trades at 467.00p.

Ultra Electronics Holdings, down 1.4%. Bank of America Merril Lynch has cut the company's rating to Underperform from Neutral.
-------
AIM ALL-SHARE WINNERS
-------
Surface Transforms, up 42%. The carbon ceramic brakes manufacturer said it has signed a pre-production contract with an unnamed international aerospace system supplier for the supply of its carbon ceramic brake discs to a US military aircraft. Surface said the contract will have a modest positive revenue impact in its 2014-15 and 2015-16 financial years, with production sales due to start in the 2016-17 financial year, subject to final qualification and flight testing. The contract has been signed on a rolling three-year basis, and the company estimates sales at contract maturity will be more than GBP1.3 million.

Cellcast, up 18%. The broadcasting company said it swung to a pretax profit in the first-half, thanks to cost cutting and a GBP2.98 million one-off payment from Sony subsidiary Entertainment Networks after Cellcast's exclusive right to manage Freeview channel Movie Mix was ended early. Cellcast posted a pretax profit of GBP2.0 million, compared with a loss of GBP914,824 a year earlier, as revenue rose to GBP9.3 million, from GBP8.3 million, thanks to the one-off payment. Cost of sales fell sharply and administrative expenses were almost halved.

SyQic, up 9.8%. The company expressed confidence for the future after it posted a rise in pretax profit in the half year to end-June, with a more than quadrupling in revenue driven by the recovery of its Indonesian business. It posted a pretax profit of GBP960,000, up from GBP35,000 in the previous year as revenue multiplied to GBP4.6 million, from GBP876,000 a year before. The company said business had improved in Indonesia following the easing of regulatory action on the industry in the middle of 2013.

Proteome Sciences, up 9.2%. The company said its PS Biomarker Services arm has won a contract with Genting TauRx Diagnostic Centre Sdn Bhd to develop diagnostic products. Under the terms of the deal, Proteome will be paid research fees totalling USD2 million in both upfront and milestone payments. In exchange, Genting TauRx will get a licence to Proteome's existing blood biomarkers for Alzheimer's and both companies will share commercialisation rights of the diagnostic assays which are developed.
-------
AIM ALL-SHARE LOSERS
-------
Inditherm, off 29%. The company reported that it swung to a pretax loss in the first half of the year as its margins were hit by a shift towards exports and its neonatal intensive care product distribution business, and it warned that the situation was likely to continue. The company posted a pretax loss of GBP173,000 for the six months to end-June, compared with the GBP4,000 profit it made a year earlier when it was buoyed by large orders from the NHS. Its revenue dropped to GBP998,000, from GBP1.0 million, while overheads increased to GBP699,000, from GBP609,000.

Falanx Group, down 14%. The security and risk management consultancy reported its first pretax profit driven by the continued turmoil in the Middle East, and predicted that it will grow significantly over the next five years. The company reported a pretax profit of GBP9,488 for the year to March 31, compared with the GBP81,274 loss it reported a year earlier when it had no revenue. Its revenue in the last financial year was GBP4.4 million. The company said its profit was low because it had spent a significant amount on recruiting new staff, establishing its cyber defence operations, and doing due diligence on potential acquisition targets.

Clean Air Power, down 13%. The company said it had to withdraw its US Genesis EDGE Dual-Fuel test engine from the testing process until it has sorted out issues that were found with the selective catalytic reduction after-treatment system on the base diesel engine. Clean Air Power said in June that the engine had met all Environmental Protection Agency emission requirements in internal testing at its facilities in the UK before It was shipped to Ricardo PLC's US unit for independent testing in preparation for an EPA certification application.

Havelock Europa, down 13%. The office and buildings interiors provider said its loss was steady in the first half, but revenue declined amid challenges for its education unit in particular, and it said its full-year results will be dependent on the fourth quarter. The pretax loss in the six months to June 30 was flat at GBP2 million, as cost cutting offset a fall in revenue to GBP32.5 million, from GBP34.2 million a year earlier. The fall was attributed to anticipated declines in business from the education sector and a quieter period for its financial services operation. Delays to the school-building programme resulted in a 6% fall in revenues for the company's Interiors arm to GBP29.5 million from GBP31.3 million a year earlier.
-------

By Neil Thakrar; neilthakrar@alliancenews.com

Copyright 2014 Alliance News Limited. All Rights Reserved.

More News
4 Aug 2022 12:33

Proteome Sciences shares rise 10% after swing to interim profit

(Alliance News) - Proteome Sciences PLC on Thursday said it swung to an interim profit in the first half of 2022 on the strength of its TMT reagents.

Read more
3 Aug 2022 15:57

TRADING UPDATES: Ensilica expects annual profit ahead of expectations

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
3 Aug 2022 15:33

Proteome reaches milestone in launch of proteomics service

(Sharecast News) - Proteome Sciences has completed its next milestone towards the launch of 'single cell proteomics' services, it announced on Wednesday, dubbed 'SysQuant SCP'.

Read more
16 May 2022 16:20

TRADING UPDATES: Proteome set for profit rise; Kromek expects loss

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

Read more
16 May 2022 13:35

Proteome Sciences maintains strong order book

(Sharecast News) - Proteome Sciences said in an update on Monday that it had maintained a strong order book after recording a small profit in 2021.

Read more
12 May 2022 11:14

IN BRIEF: Proteome Sciences secures contract with US academic group

Proteome Sciences PLC - Drug development services provider - Secures a contract from major US academic group to evaluate changes on the proteome and phospho-proteome of tissue and blood samples taken from people with and without a neurodegenerative disease. The contract's value exceeds GBP500,000. Proteome refers to entire set of proteins in a cell or organism.

Read more
12 May 2022 10:47

AIM WINNERS & LOSERS: Arc Minerals "turning point"; Titon posts loss

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday.

Read more
22 Apr 2022 12:01

DIRECTOR DEALINGS: Departing D4T4 co-founder sells GBP900,000 worth

(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced on Thursday and Friday and not separately reported by Alliance News:

Read more
31 Mar 2022 13:04

TRADING UPDATES: Impellam and Maintel in profit; Curtis Banks prospers

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
30 Mar 2022 19:23

IN BRIEF: Proteome Sciences amends GBP1 million loan with Vulpes

Proteome Sciences PLC - drug development services provider - Amends GBP1 million loan with Vulpes Investment Management Private Ltd, which was signed in the summer of 2018. Accrued interest now repayable on June 30, 2023, extended from May 1, 2022. Notes GBP700,000 is currently drawn on facility.

Read more
29 Mar 2022 15:01

UK earnings, trading statements calendar - next 7 days

Wednesday 30 March 
Anglo Pacific Group PLCFull Year Results
Bank of Cyprus Holdings PLCFull Year Results
Bowleven PLCHalf Year Results
Canadian Overseas Petroleum LtdFull Year Results
Ebiquity PLCFull Year Results
Equals Group PLCFull Year Results
Gulf Keystone Petroleum LtdFull Year Results
Inspired PLCFull Year Results
Keywords Studios PLCFull Year Results
Michelmersh Brick Holdings PLCFull Year Results
Shepherd Neame LtdHalf Year Results
Team17 Group PLCFull Year Results
Thursday 31 March 
Eleco PLCFull Year Results
BBGI Global Infrastrcture SAFull Year Results
Chesnara PLCFull Year Results
Gattaca PLCHalf Year Results
Hostelworld Group PLCFull Year Results
James Halstead PLCHalf Year Results
Mears Group PLCFull Year Results
Record PLCFull Year Results
RTW Venture Fund LtdFull Year Results
S4 Capital PLCFull Year Results
Sportech PLCFull Year Results
Proteome Sciences PLCFull Year Results
Provident Financial PLCFull Year Results
Friday 1 April 
HydrogenOne Capital Growth PLCFull Year Results
Renew Holdings PLCTrading Statement
Medica Group PLCFull Year Results
Monday 4 April 
CentralNic Group PLCFull Year Results
Elixirr International PLCFull Year Results
Xpediator PLCFull Year Results
Tuesday 5 April 
DP Eurasia NVFull Year Results
Homeserve PLCTrading Statement
Moonpig Group PLCTrading Statement
Next Fifteen Communications Group PLCFull Year Results
Quixant PLCFull Year Results
SourceBio International PLCFull Year Results
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
3 Feb 2022 22:31

TRADING UPDATES: Alliance Pharma to appeal; Braemar sales to rise

TRADING UPDATES: Alliance Pharma to appeal; Braemar sales to rise

Read more
20 Dec 2021 11:41

AIM WINNERS & LOSERS: Fundraise lifts ImmuPharma; Proteome wins deal

AIM WINNERS & LOSERS: Fundraise lifts ImmuPharma; Proteome wins deal

Read more
20 Dec 2021 10:45

Proteome Sciences shares climb on GBP1 million contract win

Proteome Sciences shares climb on GBP1 million contract win

Read more
20 Dec 2021 10:08

Proteome Sciences secures $1m contract with pharmaceutical major

(Sharecast News) - Proteomics and biomarker research firm Proteome Sciences has secured a contract valued at more than £1.0m from an unnamed major pharmaceutical company.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.